Pulmonary Disorders and COVID-19: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 21: Line 21:


===Increased mortality in COPD patients===
===Increased mortality in COPD patients===
*According to a study conducted in China, having an underlying comorbidity such as chronic obstructive pulmonary disease (COPD) conferred a mortality hazard ratio of 2.681, even after adjusting for smoking status.<ref name="pmid32217650">{{cite journal| author=Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM | display-authors=etal| title=Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. | journal=Eur Respir J | year= 2020 | volume= 55 | issue= 5 | pages=  | pmid=32217650 | doi=10.1183/13993003.00547-2020 | pmc=7098485 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32217650  }} </ref><ref>https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184</ref>
*According to a study conducted in China, having an underlying comorbidity such as chronic obstructive pulmonary disease (COPD) conferred a mortality hazard ratio of 2.681, even after adjusting for smoking status.<ref name="pmid32217650">{{cite journal| author=Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM | display-authors=etal| title=Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. | journal=Eur Respir J | year= 2020 | volume= 55 | issue= 5 | pages=  | pmid=32217650 | doi=10.1183/13993003.00547-2020 | pmc=7098485 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32217650  }} </ref><ref>https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184</ref><ref>https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184</ref>


==References==
==References==

Revision as of 15:47, 18 June 2020

To go to the COVID-19 project topics list, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Overview

Complications

Acute respiratory distress syndrome

Pneumonia

Pulmonary embolism

Hypoxemia

Superinfection

Respiratory failure

Increased mortality in COPD patients

  • According to a study conducted in China, having an underlying comorbidity such as chronic obstructive pulmonary disease (COPD) conferred a mortality hazard ratio of 2.681, even after adjusting for smoking status.[1][2][3]

References

  1. ↑ Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM; et al. (2020). "Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis". Eur Respir J. 55 (5). doi:10.1183/13993003.00547-2020. PMC 7098485 Check |pmc= value (help). PMID 32217650 Check |pmid= value (help).
  2. ↑ https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184
  3. ↑ https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184
Retrieved from "https://www.wikidoc.org/index.php?title=Pulmonary_Disorders_and_COVID-19&oldid=1614638"